Sign in

CIK 0001721484

  • Emerging growth company

Longeveron Inc.

Sign in to watch
Ticker
LGVN
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
472174146
Phone
+1 305-302-7158
Business address
1951 NW 7TH AVENUE, SUITE 520, MIAMI, FL, 33136
Former names
LONGEVERON LLC
  1. 4 Shares withheld for taxes Chief Financial Officer gave up 4,098 shares (to pay taxes)
  2. 4 Shares withheld for taxes Chief Executive Officer gave up 5,123 shares (to pay taxes)
  3. 4 Shares withheld for taxes General Counsel, Secretary gave up 992 shares (to pay taxes)
  4. 4 Shares withheld for taxes Chief Medical Officer gave up 3,074 shares (to pay taxes)
  5. 4 Open-market buy Director bought 5,000 shares at $1.31 ($6,545)
  6. 4 Open-market buy Director bought 10,000 shares at an average $1.43 ($14,257)
  7. 4 Open-market buy Director bought 10,000 shares at $1.35 ($13,500)
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 4 Derivatives Options or other derivatives
  15. 4 Derivatives Options or other derivatives
  16. 4 Shares withheld for taxes General Counsel, Secretary gave up 815 shares (to pay taxes)
  17. 4 Shares withheld for taxes Chief Financial Officer gave up 4,078 shares (to pay taxes)
  18. 4 Shares withheld for taxes Chief Medical Officer gave up 3,059 shares (to pay taxes)
  19. 4 Exercise or conversion Chief Scientific Officer acquired 5,000 shares (option exercise)
  20. 4 Exercise or conversion General Counsel, Secretary acquired 2,000 shares (option exercise)

Page 7 of 13 · 246 filings